MedTrace Logo

Dexamethasone for the Prevention of Postoperative Cognitive Dysfunction

NCT01332812 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2015-09-10

No results posted yet for this study

Summary

This study aims to evaluate the possible effect of dexamethasone on prevention of cognitive dysfunction in the postoperative period of elderly patients undergoing to surgery under general anesthesia.

Conditions

  • Postoperative Cognitive Dysfunction

Interventions

DRUG

Dexamethasone

a dose of 8 mg of dexamethasone will be administered intravenously before induction of general anesthesia

OTHER

control group

General anesthesia, without additional interventions

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • Duke University

    collaborator OTHER

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Maria José C Carmona, M.D. · Faculty of Medicine of the University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-02-28
Completion
2013-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01332812 on ClinicalTrials.gov